Wendy Lane

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

John B. Buse, Satish K. Garg, Julio Rosenstock et al. · Diabetes Care · 2018 · 228 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes

Wendy Lane, Timothy S. Bailey, Gregg Gerety et al. · JAMA · 2017 · 207 citations

Medicine, Endocrinology, Pharmacotherapy +17

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Irl B. Hirsch, Bruce W. Bode, Satish K. Garg et al. · Diabetes Care · 2005 · 200 citations

Medicine, Endocrinology, Pharmacology +17